(Algemeiner) Benjamin Kerstein - Israeli company Savicell has developed a successful blood test for lung cancer, allowing the disease to be detected and treated in its earliest stages, thus boosting the chances of recovery. Dr. Shafrira Shai, development and production manager at Savicell, said: "This gives us exact information on the condition of the person, if he's in a pre-cancerous condition, the beginning stages of cancer, or other possibilities." Eyal Davidovitch, vice president of operations, said: "Statistics indicate that if you discover lung cancer in an early stage, the chances of recovery wander on average between 50-80%. If you identify it at a late stage, we're talking about 4%....Lung cancer is the number one killer." Current methods for detecting lung cancer tend to be cumbersome and time consuming, and are usually employed only after severe symptoms develop. With the new test, however, "you come to the doctor for a test and identify cancer," said Davidovitch. "It's simply a life-saver."
2018-12-21 00:00:00Full ArticleBACK Visit the Daily Alert Archive